These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 6245350)
1. [Clinical aspects and importance of human herpex simplex infections. Results of herpes antigen therapy]. Wassilew SW; Nasemann T MMW Munch Med Wochenschr; 1980 Jan; 122(1):25-7. PubMed ID: 6245350 [TBL] [Abstract][Full Text] [Related]
2. [Therapy of recurrent herpes simplex]. Eichmann A Z Hautkr; 1977 Apr; 52(8):475-82. PubMed ID: 194427 [TBL] [Abstract][Full Text] [Related]
3. [Results of treatment with the Herpes simplex antigen Lupidon H, resp. Lupidon G]. Schmersahl P; Rüdiger G Z Hautkr; 1975 Feb; 50(3):105-12. PubMed ID: 179231 [TBL] [Abstract][Full Text] [Related]
5. [New possibilities of herpes simplex therapy in the dermatological practice]. Weitgasser H Hautarzt; 1973 Jul; 24(7):298-301. PubMed ID: 4541990 [No Abstract] [Full Text] [Related]
6. [Relationship between EB virus, Cytomegalo virus, herpes simplex virus and coxsackievirus infection and relapse of multiple sclerosis]. Feng ZJ; Zhao RG; Wang DX Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Dec; 22(6):472-4. PubMed ID: 19544649 [TBL] [Abstract][Full Text] [Related]
7. [Herpes simplex infections]. Kimmig W Z Hautkr; 1989 Apr; 64(4):266-8, 271. PubMed ID: 2544060 [TBL] [Abstract][Full Text] [Related]
8. [Antigen therapy of recurring herpes simplex with herpes simplex vaccine LUPIDON H and G]. Schneider J; Rohde B Z Haut Geschlechtskr; 1972 Dec; 47(24):973-80. PubMed ID: 4346378 [No Abstract] [Full Text] [Related]
9. Cell-mediated immune responses in patients with recurrent Herpes Simplex infections. II. Infection-associated deficiency of lymphokine production in patients with recurrent herpes labialis or herpes progenitalis. O'Reilly RJ; Chibbaro A; Anger E; Lopez C J Immunol; 1977 Mar; 118(3):1095-1102. PubMed ID: 191524 [TBL] [Abstract][Full Text] [Related]
10. [Controlled clinical study of the herpes antigens LUPIDON H and LUPIDON G]. Weitgasser H Z Hautkr; 1977 Jun; 52(11):625-8. PubMed ID: 196421 [TBL] [Abstract][Full Text] [Related]
11. Immunotherapy with inactivated polyvalent herpes vaccines. Dundarov S; Andonov P; Bakalov B; Nechev K; Tomov C Dev Biol Stand; 1982; 52():351-8. PubMed ID: 6299844 [No Abstract] [Full Text] [Related]
12. Seventeen years of application of herpes vaccines in Bulgaria. Dundarov S; Andonov P Acta Virol; 1994 Aug; 38(4):205-8. PubMed ID: 7879710 [TBL] [Abstract][Full Text] [Related]
13. [Herpes simplex virus, type II: microbiology and clinical experiences with attenuated vaccine]. Nasemann T; Schaeg G Hautarzt; 1973 Apr; 24(4):133-9. PubMed ID: 4351533 [No Abstract] [Full Text] [Related]
14. [Problems and treatment of recurrent herpes simplex]. Fanta D; Kraft D; Söltz-Szöts J Z Hautkr; 1974 Jul; 49(14):597-606. PubMed ID: 4369653 [No Abstract] [Full Text] [Related]
15. [Experience with the combined treatment of recurrent herpes using larifan and a herpetic vaccine]. Potekaev NS; Nosik NN; Samgin MA; Kudratullaev KN; Lavrukhina LA Klin Med (Mosk); 1992 Jan; 70(1):67-70. PubMed ID: 1318984 [TBL] [Abstract][Full Text] [Related]
16. [E1The mechanism of action of Lupidon]. Remy W Z Hautkr; 1977 Apr; 52(8):470-4. PubMed ID: 194426 [TBL] [Abstract][Full Text] [Related]
17. Therapy of herpes simplex with heat inactivated Herpes virus hominis type 1 and type 2. Kitagawa K Z Hautkr; 1973 Jul; 48(13):533-5. PubMed ID: 4361462 [No Abstract] [Full Text] [Related]